The first topical HIV prevention method to be submitted for regulatory approval, the dapivirine vaginal ring (DVR) is a silicone ring, developed by the International Partnership for Microbicides (IPM). A recent article, written by Susan Brink for NPR, discusses how many African communities will have access to the vagina ring to reduce the risk of acquiring HIV from an infected partner.
The ring is inserted in the vagina and slowly releases an antiretroviral drug called dapivirine over one month to help protect against HIV at the site of potential infection. Little of the drug is absorbed elsewhere in the body, making it unlikely to be found in high concentrations in the bloodstream and other body tissues. This may reduce side effects as well as the risk of development of HIV resistance.
To learn more, go to IPM’s website to discover more HIV Prevention Products for Women worldwide.
Related Tag: Jacksonville STD Clinic